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Metabolic Syndrome X  




 The aim was to perform a review in order to elucidate the actions and efficacy of different antioxidant 
supplements used on Metabolic Syndrome. The articles were searched during October of 2015 to December of 
2018, using the databases PubMed and Web of Knowledge. The keywords used were: “Metabolic Syndrome” 
AND “dietary supplements” OR “antioxidant”. The included articles were published from 2010 and in English. It 
was applied for articles selection inclusion and exclusion criteria. The articles that fulfilled criteria were 
analyzed through a full-text reading. Search results in 368 articles (PubMed: 198; Web of Knowledge: 170). 
After eliminating duplicated data and applying criteria, 16 articles were included to the review. The antioxidant 
supplements used on the studies included eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), nigella 
sativa (NS) and garlic, superoxide dismutase (SOD), cholecalciferol, Coenzyme Q10 (CoQ10), quercetin 
dehydrate, glycine, α-lipoic acid (ALA), glutathione precursor (F1), taurine, phenolic acids, red yeast rice-olive 
extract, curcumin, goji berry and arginine. Findings demonstrate a decrease in oxidative stress by increasing 
antioxidant enzyme activity, G6DH, Nrf2 with a consequently positive effect on insulin sensitivity, glucose 
tolerance, improvement in lipid profile, decrease on inflammatory and endothelium dysfunction markers with 
antioxidant supplements. Therefore, we could conclude that supplementation with antioxidant potential is able 
to ameliorate parameters of Metabolic Syndrome. 
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 O propósito desta revisão foi elucidar as ações e a eficácia de diferentes suplementos antioxidantes utilizados na 
Síndrome Metabólica.  Os artigos foram pesquisados no período durante Outubro de 2015 a dezembro de 2018, 
utilizando as bases de dados PubMed e Web of Knowledge. As palavras-chave usadas foram: “Metabolic 
Syndrome” AND “dietary supplements” OR “antioxidant”. Foram incluídos os artigos publicados a partir de 2010 
e no idioma inglês. Os critérios de inclusão e exclusão foram aplicados para a seleção dos artigos, e aqueles que 
preencheram os critérios foram analisados por meio da leitura completa do texto. A busca resultou em 368 
artigos (PubMed: 198; Web of Knowledge: 170) e, após a eliminação dos artigos duplicados e a aplicação dos 
critérios, 16 artigos foram selecionados para revisão. Os suplementos antioxidantes utilizados incluíram ácido 
eicosapentaenóico (EPA) e ácido docosahexanóico (DHA), Nigella sativa (NS) e alho, superóxido dismutase 
(SOD), colecalciferol, Coenzima Q10 (CoQ10), quercetina, glicina, ácido α-lipóico (ALA), precursor da glutationa 
(F1), taurina, ácidos fenólicos, red yeast rice-olive extract, curcumina, goji berry e arginina. Os resultados 
demonstraram que a utilização dos suplementos antioxidantes levou à uma redução no estresse oxidativo 
devido ao aumento da atividade das enzimas antioxidantes, G6DH e Nrf2, com um consequente efeito positivo 
na sensibilidade à insulina, tolerância à glicose, melhora no perfil lipídico, redução de marcadores de inflamação 
e de disfunção endotelial. Portanto, a partir dos resultados atuais é possível concluir que suplementos com 
potencial antioxidante podem melhorar parâmetros envolvidos na síndrome metabólica.  
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INTRODUCTION 
Metabolic Syndrome (MetS) has a direct relationship with 
an increased risk of the chronic non-communicable diseases 
(NCD) mainly type 2 diabetes mellitus (T2DM) and 
cardiovascular diseases (CVD) development. In Brazil the 
prevalence of MetS ranges between 18% to 30% depending 
on the region, being more frequent in the elderly1-8. The 
diagnosis consists in the inclusion of three or more variables, 
related to glucose metabolism, obesity and increase in visceral 
fat, dyslipidemia and hypertension. If the incidence of MetS is 
not reversed, can represent the main risk factor for NCD9-11. 
In conditions related to the development of MetS, such 
as, obesity, type 2 diabetes mellitus (DM) and hypertension 
there is a high production of oxidative compounds, which is 
associated with oxidative stress12. There are several 
pathways that are directly or indirectly related to the 
formation of reactive oxygen species (ROS), such as the 
leaking in electron transport chain, xanthine oxidase 
pathway, in cases of DM the sorbitol pathway, among others 
mechanisms. One of the main mechanisms that augments 
this vicious cycle in MetS is the excessive production of anion 
superoxide (O2•-) through mitochondrial electron chain 
transport and via nicotinamide adenine dinucleotide 
phosphate-oxidase (NADPH oxidase). Additionally, this 
enzyme can be activated after chronic exposure of glucose, 
causing hyperglycemia that overloads the stimulation of 
insulin receptors, hence occurs the production of hydrogen 
peroxide (H2O2), that could be utilized as substrate to 
Fenton reaction, leading to hydroxyl radical (HO•)13, 14. Thus, 
these free radicals could disturb metabolic pathways and 
establishing oxidative stress, resulting in oxidation of 
proteins, lipids and nucleic acids. Besides, oxidative stress 
induce higher expression of proinflammatory interleukin 
occasioning inflammation15, 16. 
Obesity, as the leading factor to MetS, along with 
dyslipidemia, DM and hypertension, increase O2•-, H2O2, 
NADPH oxidase, lipid peroxidation, as well as tumor necrosis 
factor alpha (TNF-α), C reactive protein (CRP), plasmatic 
cholesterol, oxidized low density lipoprotein cholesterol 
(LDL), moreover reducing antioxidant enzymes, like 
superoxide dismutase (SOD), catalase (CAT) and ratio of 
reduced glutathione to oxidized glutathione (GSH/GSSG)17. 
Besides, studies investigating antioxidant status on patients 
diagnosed with MetS shows a low content of antioxidant 
like, vitamin E, vitamin C and carotenoid that was inversely 
related with MetS18, 19.  
Antioxidant compounds are used as a strategy to manage 
risks involved on MetS, these supplements act increasing 
antioxidant defense and attenuating oxidative stress, 
through scavenging properties of free radicals. This 
scavenging effect consequently affects reducing 
inflammation, which is induced by ROS, as well as oxidation 
of protein and lipid peroxidation. Also, the dietary 
antioxidants could modulate glucose and fat metabolism, 
reduce plasma glucose, blood pressure and oxidation of LDL 
cholesterol and improve high density lipoprotein cholesterol 
(HDL), preventing co-morbidities of this syndrome, being 
beneficial to the conditions9, 10, 20. 
Considering the strict relation of MetS with oxidative 
stress and the beneficial effects performed by antioxidant 
supplements, the aim of this study is to perform a review in 
order to investigate actions and efficacy of antioxidant 
supplements used in MetS. 
METHODS 
In this review we performed a review of the literature 
regarding the antioxidant supplementation used in MetS 
and actions attributed to its use. The articles were 
searched during October of 2015 to December of 2018, 
utilizing databases Public Medline (PubMed) and Web of 
Knowledge. 
The inclusion criteria to select the articles were: 1) 
studies published from 2010 to 2015; 2) written in English; 3) 
randomized clinical trials; 4) experimental studies performed 
with humans, rats, mice and hamsters; 5) experimental 
studies using high fat diet or fructose administration as 
method to induce MetS; 6) present as outcome antioxidant 
analysis. The exclusion criteria were: 1) articles without 
abstract; 2) in vitro studies; 3) administration of supplement 
by addition on water or food/beverage with antioxidant 
content; 4) articles without MetS variables; 5) not containing 
supplement protocol. 
Those articles that fulfilled the criteria were selected to 
full-text analyzes. The analysis consisted in reading studies 
and collect data of each research, specifically: authors/date, 
sample, methodological aspects and main results. Thus, was 
possible to identify relevant aspects in the reading of the 
studies. In order to search the published articles, we used 
MeSH terms for keywords: “Metabolic Syndrome”, “dietary 
supplements” and “antioxidant”. 
RESULTS   
The search resulted in 16 articles, after applied the 
inclusion and exclusion criteria (Figure 1). Additionally, the 
selected studies are organized in order to elucidate the 
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characteristics of each protocol, as well its main outcomes 
(Chart 1).  
Figure 1: Process of article selection. 
 
Effects of antioxidant supplementation on MetS   
The supplements used on the studies selected to our 
review comprise eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), which is the most common n-3 
polyunsaturated fatty acid (PUFA) in fish oil, nigella stevia 
(NS) and garlic, SOD, cholecalciferol, Coenzyme Q10 (CoQ10), 
quercetin dehydrate, glycine, α-lipoic acid (ALA), glutathione 
precursor (F1), taurine, phenolic acids, red yeast rice-olive 
extract, curcumin, phospholipidated curcumin, goji berry and 
arginine. All of these compounds are considered dietary 
supplements with potential antioxidant effect. 
Oxidative stress measures performed on articles showed 
an increase on antioxidant defense with the 
supplementation protocols, as demonstrated by the study of 
Ibitoye & Ajiboye, which observed an increase in SOD, CAT, 
GPx and GSH-Red with supplementation of phenolic acids50. 
As well as, an increase on SOD and CAT activity with different 
ratios of EPA:DHA mixtures, GSH, CAT activity and total 
antioxidant capacity with goji berry23, 51, 53-55. Besides, an 
increase in pro-oxidant–antioxidant balance after curcumin 
supplementation, an improvement on CAT activity in NS and 
garlic supplementation and restore levels of SOD and CAT in 
adipose tissue with SOD supplementation demonstrated by 
Al-Rasheed and Carillon, respectively21, 22, 52. 
Chart 1: Main results of articles selected to review. 
Study Sample Aim Intervention Duration Main results 
Ibitoye & 
Ajiboye, 2018 
Male Wistar rats 
(n=35) 
Evaluated the effect of 
caffeic, ferulic, gallic and 




inflammation and oxidative 
stress in high-fructose diet-
induced metabolic 
syndrome in rats. 
High-fructose diet for six 
weeks to indice MetS. 
Supplemtnation of caffeic, 
ferulic, gallic and 
protocatechuic acids (40 
mg/kg body weight) for four 
weeks starting from sixth 
week of diet treatments. 
10 weeks ↓Body weight, BMI and abdominal 
circumference 
↓Blood glucose, HOMA-IR and 
insulin 
↑Adiponectin and HDL-c 
↓Total cholesterol, LDL-C, VLDL-c and 
TG 
 ↓Cardiac index, atherogenic index 
and Coronary artery index 
↓TNF-α, IL-6 and IL-8 







oxidative effect of a 
supplement combining red 
yeast rice and olive extract. 
Supplementation of red 
yeast rice-olive extract (RYR-
olive extract; 10.82 mg of 
monacolins and 9.32 mg of 
hydroxytyrosol per 
Cholesfytolplus capsule) or 
placebo. One capsule/day. 
8 weeks ↓ Lp-PLA2 
↓Plasma OxLDL 
No difference in MDA and 8-OHdG 
Ghazimoradi 




Investigate the effect of 
curcumin supplementation 
on the serum pro-oxidant–
antioxidant balance (PAB). 
Patients received 1 g/day of 
simple curcumin or 
phospholipidated curcumin 
(containing 200 mg of pure 
curcumin), or placebo. 
6 weeks ↑Pro-oxidant–antioxidant balance  
No difference in  phospholipidated 
curcumin 







parameters in patients 
with metabolic syndrome 
after the consumption of 
goji berry. 
Addition of 14 g of the 
natural form of goji berry in 
the diet. 
45 days ↓Waist circumference 
↓Total cholesterol, LDL-c and VLDL-c 
↑ HDL-c 
↓ Lipid peroxidation 
↑ GSH, total antioxidant, CAT 
No difference in inflammatory 
biomarkers 
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Chart 1 (continued) 
Study Sample Aim Intervention Duration Main results 
Medeiros et 
al., 2017 
Male Wistar rats 
(n=35) 
Investigate the isolated 
and combined effects of 
aerobic training and 
arginine supplementation 
on metabolic variables and 
vascular reactivity in rats at 
high risk for developing the 
metabolic syndrome. 
Supplementation of 880 
mg/kg/day of L-arginine and 
aerobic training with 
moderate-intensity (50–75% 
maximal running speed) with 
a 0–7% inclination on a 
treadmill, 4 d/week. 
8 weeks ↓ Adipose tissue 
↓ Insulin  
↑ Endothelium-dependent 
vasodilation  
↑ Hyperreactivity to phenylephrine 
Mohammadi 




Investigate the effect of 
curcumin supplementation 
on serum vitamin E levels. 
Patients received 1 g/day of 
unformulated curcumin or 
lecithinized curcumin 
(containing 200 mg of pure 
curcumin), or placebo. 
6 weeks No change of serum vitamin E pre 
and post: 




Toribio et al., 
2015 
Female SHROB 
rats, as an 
animal model for 
the MetS (n=28) 
Evaluate the effect 
EPA/DHA supplementation 
on the markers of CVD and 
OS.  
Supplementation of 
EPA/DHA mixtures at 
different proportions, 
namely 0,8ml/kg of 1:1, 2:1 
and 1:2. 
13 weeks ↓LDL-c 
↓total cholesterol in 2:1 and 1:2 
EPA/DHA 
↓TAG concentrations 1:1 and 2:1 
↓ CRP in 1:1 and 2:1 
↑VCAM-1 in 1:2 group 
No influence on  plasma levels of PAI-
1  
↑SOD activity in the erythrocytes, 
kidneys, abdominal fat, heart and 
brain (1:1), kidneys and heart (2:1) 
and in the heart (1:2) 
↑ CAT activity erythrocytes 
and kidneys (2:1) 
↓ CAT in brain of the (1:1) 





Male Wistar rats 
(n=50) 
Investigate if co-
administration of nigella 
sativa and garlic in 
prevention or amelioration 
of MetS.  
Supplementation of nigella 
sativa (200mg/day) and 
garlic (250mg/kg/day). 
8 weeks ↓ Body weight 
↓ Blood glucose  
↓ TAG 
↓TC and LDL-c  
↑ HDL-c 
↑CAT activity, G-6-PDH, LDH  
 




3 weeks old 
(n=17) 
Evaluation of SOD 
supplementation on 
metabolic parameters in 
cafeteria diet to induce 
obesity in hamsters.  
Supplementation of SOD (10 
U/day). 
4 weeks ↓Body weight 
No change in food intake 
↓Insulin resistance (HOMA-IR) and 
insulinemia 
↓adipose tissue weight 
↓adipocytes size 
No effect on adipocytes hyperplasia 
↓hydroxylproline content in adipose 
tissue 
↓percentage of fibrous tissue 
↑lipolytic activity through restoring 
HSL expression 
↑expression of antioxidant enzymes  




rats (n=18)  
Assessment of 
cholecalciferol 
supplementation for on 





2 weeks Positive effects on memory in 
hepatosteatosis rats 
No difference in liver tissue 
histopathology 
↓ brain TNF-α in control and 
hepatosteatosis rats 
↓plasma MDA in control and 
hepatosteatosis rats 
Orlando et al., 
2014 
Male rats with 
MetS (n=40) 
Determine the effect of 
HFD and CoQ10 
supplementation on the 
redox state of hemoglobin 
in erythrocytes.  







↑content of CoQ10/cholesterol in 
plasma Efficiently counteract the HFD 
associated oxidation in the circulatory 
system.  
↓hemoglobin oxidation 
↓CoQ10 oxidation in lipoproteins 
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Chart 1 (continued) 
Study Sample Aim Intervention Duration Main results 
Pfeuffer et al., 
2013 
Subjects with 
MetS (48-68 y) 
(n=49) 
Investigate the impact of 
quercetin intervention on 
endothelial function in 
patients carriers of the 




8 weeks ↓Waist circumference 
↓BMI and body weight in APOE3 
↑BMI slightly in APOE4 
↑HDL-C concentrations 
↓Triacylglycerols 
↓Total GSH concentration in 
erythrocytes 




MetS (35-65 y) 
(n=60) 
Evaluate the effects of 
daily administration of 
glycine supplement on 
antioxidant enzymes and 
lipid peroxidation.  
Glycine supplementation (15 
g/day). 
12 weeks ↑HDL-c and TC in male 
↑HDL-c in female 
↓LDL-c  




↓ SOD2 mRNA levels 





Effect of α-lipoic acid and 
CoQ10 supplementation on 
plasma levels of lipids, 
asymmetric dimethyl 
arginine, oxidative stress 
and vascular changes.  
α-lipoic acid (100 mg/kg/day) 
and CoQ10 (10 mg/kg/day) 
supplementation. 
5 weeks ↓ Body weight 
↓ Total cholesterol LDL-c, TG  
↑ HDL-c 
↓Glucose, HOMA-IR levels 
↓ADMA, MDA andNO 





Male mice Apo E 
-/- (n=24) 
Investigate a preventive 
role of a glutathione 
precursor on hepatic 
steatosis.  
Cystine supplementation (3 
mg/kg). 
16 weeks ↓ Weight gain 
↓ Hepatomegaly  
↓ TG levels  
Prevent hepatic steatosis and 
accumulation of lipids on hepatocytes  
↓ apoptosis index on liver  
↑ GSH/GSSG ratio 
↓8-OHdG levels  
↓4-HNE expression 
↑ Nrf2 
Supress FAS levels  
Restore phospho-AMPK 




Male Wistar rats 
(n=32) 
Effects of taurine 
supplementation for 35 
days in HFD-induced IR.  
Taurine supplementation 
(300 mg/day). 
35 days ↓ Weight gain  
↓ OGTT and HOMA 
↑ Glucose tolerance  
↓TG levels  




No change in HHcy 
 
4-HNE: 4-hydroxynonenal protein; 8-OHdG: 8-hydroxy-2'-deoxyguanosine; A1c: glycated hemoglobin; ALA: α-lipoic acid; AMPK: 5': adenosine monophosphate-activated protein kinase; 
APOE: apolipoprotein E; BMI: body mass index; CAT: catalase; CoQ10: Coenzyme Q10; CRP: C-reactive protein; DHA: Docosahexaenoic acid; EPA: Eicosapentaenoic acid; FAS: fatty acid 
synthase; FFA: free fatty acids; G6PD: glucose-6-phosphate dehydrogenase; GPx: glutathione peroxidase; GSH/GSSG: ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG); 
GSH-Red: reduced glutathione;  HDL-c: high density lipoprotein cholesterol; HFD: high fat diet; HHcy: hyperhomocysteinemia; HOMA-IR: homeostatic model assessments a measure of 
insulin resistance; ADMA: asymmetric dimethyl arginine; HSL: hormone sensitive lipase; ICAM-1: intercellular adhesionmolecule-1; JNK: c-Jun-NH2-terminal kinase; LDL-c: low density 
lipoprotein cholesterol; LPX: lipid peroxidation; Lp-PLA2: lipoprotein-associated phospholipase A2; MetS: metabolic syndrome; MDA: malondialdehyde; NO: nitric oxide; NOx: nitric oxide 
metabolites concentration; Nrf2: nuclear factor-erythroid-2-related factor 2; OGTT: oral glucose tolerance test; OxLDL: oxidised low-density lipoprotein; p-38 MAPK: p38 mitogen-
activated protein kinase; PAI-1: plasminogen activator inhibitor-1; PON: paraoxonase activity; SDMA: symmetric dimethyl arginine; SHROB: Spontaneously hypertensive obese; SNO-Hb: 
S-nitrosohemoglobin; SOD: superoxide dismutase; TAC: total 
A reduction on plasmatic malondialdehyde (MDA) was 
observed with cholecalciferol, α-lipoic acid, CoQ1, glycine and 
goji berry supplementation. In addition glycine, phenolic acids 
and NS and garlic supplementation improve glucose-6-
phosphate dehydrogenase (G6PD)21, 24-26, 50, 53. Also, the 
glutathione precursor, F1, decreased 4-hydroxynonenal 
protein (4-HNE), which represents one of the products of lipid 
peroxidation. Additionally, it was demonstrated a reduction in 
8-hydroxy-2'-deoxyguanosine levels (8-OHdG), which indicate 
oxidative DNA damage. Beyond that, the redox sensitive 
transcriptor factor (Nrf2) was significantly augmented with a 
novel cysteine based glutathione precursor27. 
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The supplementation of α-lipoic acid, CoQ10, F1 and 1:1, 
2:1 mixtures of EPA:DHA were able to improve GSH/GSSG 
ratio23, 24, 27. Taurine supplementation improved total 
antioxidant capacity (TAC), paraoxomase activity (PON) and 
reduced the concentration of nitric oxide metabolites 
(NOx)28. In the study of Orlando and colleagues (2014), 
CoQ10 supplementation ameliorated the oxidation of 
hemoglobin and plasmatic ubiquinone and increased the 
synthesis of methemoglobin (Met-Hb), all variables induced 
by HFD29. 
Conversely, quercetin does not appears to be a worthy 
antioxidant supplement, based on Pfeuffer, 2013, in view of 
the slightly reduction in GSH concentration and higher TNF-α 
in both genotypes APOE in post prandial analysis30. Also, 
curcumin and lecithinized curcumin supplementation 
demonstrated no effects on vitamin E serum levels55. 
The improvement on antioxidant defense, consequently 
improving antioxidant state, was related with a reduction of 
insulin resistance, blood glucose, glycated hemoglobin and 
enhancement on glucose tolerance with NS and garlic, SOD, 
α-lipoic acid, CoQ10, glycine, taurine supplementation, 
phenolic acids and arginine21, 22, 24, 25, 28, 50, 54. In addition, it 
was observed higher lipolytic activity and lower percentage 
of fibrous tissue, reducing adipocyte size and tissue weight 
with SOD supplementation in the study of Carillon and 
colleagues, furthermore, F1 supplementation effectively 
suppressed FAS levels22, 27. 
When assessed inflammation biomarkers, phenolic acids 
supplementation reduced TNF-α and IL-8, while 
cholecalciferol supplementation reduced TNF-α and 
EPA:DHA mixtures decreased CRP, despite increased vascular 
cell adhesion molecule (VCAM)23, 26, 50. Besides α-lipoic acid 
and CoQ10 reduced nitric oxide (NO), asymmetric dimethyl 
arginine (ADMA) and perivascular lymphocytic infiltration 
and glycine supplementation improved S-nitrosohemoglobin 
(SNO-Hb), indicating positive antioxidant activity of these 
compounds24, 25. 
Related to lipid profile, it was observed a reduction in TC, 
LDL-c, TG and an increase in HDL-c levels on EPA:DHA, α-
lipoic acid, CoQ10, glycine supplementation, F1, taurine, 
phenolic acids and goji berry. As well as, a reduction in 
plasma oxidised-LDL (OxLDL) and lipoprotein-associated 
phospholipase A2 (Lp-PLA2) after supplementation of red 
yeast rice and olive extract 23-25, 27, 28, 50, 51, 53. In addition, F1 
and taurine supplementation reduced atherogenic index and 
apoptosis index, respectively, while phenolic acids 
supplementation was able to reduced atherogenic, cardiac 
and coronary artery indices27, 30, 50. In Pfeuffer and colleagues 
study, despite no beneficial effect on oxidative stress 
variables showed an increase in HDL-c and a reduction in 
TG27, 30. 
Regarding endothelial function, Medeiros and colleagues 
demonstrated an increase in endothelium-dependent 
vasodilation and hyperreactivity to phenylephrine in rats 
supplemented with arginine54. 
DISCUSSION 
Antioxidant supplementation on oxidative stress 
The main finding of the present review is the efficacy of 
dietary supplements on MetS, specifically its effects on 
oxidative stress biomarkers. The articles selected in this 
review demonstrate that occurs oxidative stress in MetS. 
This condition is generated owing to an elevated formation 
of ROS induced predominantly by the chronic state of 
hyperglycemia, as consequence of non-enzymatic protein 
glycation, formation of advanced glycation end products 
(AGEs) and glucose autoxidation. The majority of the 
selected studies was composed by experimental 
investigations with rats, so our discussion should be 
interpreted with wariness to not directly extrapolate to 
clinical repercussions. Likewise, the production of O2•- 
through activation of NADPH oxidase is a parallel process, 
which occurs after stimulation of insulin receptors13, 31. This 
context could be prevented and reversed when associated 
with antioxidant supplements, mainly through an increase 
on antioxidant defense, for instance, intrinsic antioxidant 
enzymes, such as CAT, SOD, GPx activities in addition with an 
improvement of the ratio of GSH/GSSG and G6PD, as well as, 
increased pro-oxidant–antioxidant balance and total 
antioxidant capacity, knowing that these parameters are 
notably reduced in hyperglycemia and in 
hypercholesterolaemia13, 15, 32, 33, 52, 53.  
The increase on antioxidant enzymes activity observed 
with supplements, such as EPA:DHA, garlic and NS, phenolic 
acids and goji berry which are known to perform 
hypoglycemic and hypocholesterolemic effect, may happen 
due to the activation of signaling pathways, expression of 
genes and enhancement of endogenous antioxidants21-24, 50, 53. 
The transcriptional factor Nrf2, which was activated with F1 
administration, appears to be the mechanism in common of 
antioxidant supplements responsible for enhancing 
antioxidant capacity, in addition with antioxidant response 
element (ARE) pathway, therefore promotes the transcription 
of a large number of cytoprotective genes. The increase of 
ROS production lead to activation of Nrf2 and increase of ARE 
that cause amplification of antioxidant defense 27, 34. 
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In addition, the improvement of the ratio of GSH/GSSG, 
observed with ALA, CoQ10, glutathione and phenolic acids 
and goji berry supplementation, occurs owing to increasing 
G6PD, in view of the necessity of this enzyme to formation of 
NADPH, which is required to maintain GSH in its reduced 
form. Contributing to this, phenolic acids supplementation 
demonstrated an increase in G6FD together with the 
increase in GPx and GSH-Red. Considering that, the G6PD 
activity is associated with lower peroxidation of lipids and 
higher gene expression of mitochondrial SOD2 observed 
after glycine administration, it might be suggested that this 
antioxidant generate a redox status. These actions are 
sustained through glycine ability to increase GSH synthesis in 
tissues, by being one of the key amino acids of GSH 
molecule35, 36, 50, 53. In El Mesallamy study, a consequently 
reestablishment of TAC, as well as PON activity, it was 
observed with the increase in GSH levels, due to taurine 
supplementation may spare a precursor amino acid of GSH, 
cysteine 28. 
As G6PD is the main source of NADPH, which is used by 
eNOS to synthesize NO, it improves NO bioavailability that 
are impaired on oxidative stress, since the generation of 
O2•- produces peroxynitrite (NOO•) by reacting with  NO. 
Therefore, a higher expression of G6PD can lower ROS 
formation and increase antioxidant capacity, reversing 
oxidative stress24. Besides, a reduction on NOx 
concentration, that indicates lower NO bioavailability and 
possible peroxynitrite formation, it was observed with 
taurine supplementation, which may occur by inhibiting 
iNOS expression and scavenging O2•- 28, 37. 
Additionally, can be demonstrated an improvement on 
oxidation of hemoglobin (Met-Hb) and plasmatic 
ubiquinone, after CoQ10 supplementation. A decrease in 
Met-Hb formation represents positive results by reducing 
the incorporation of glucose by non-enzymatic processes in 
vulnerable sites of Hb protein. The Met-Hb is used as a 
marker of oxidative stress since when oxidized can release 
O2•-, increasing its products, H2O2 or hydroxyl radicals38. A 
decrease on plasmatic CoQ10 concentration was observed 
jointly with oxidized CoQ10 and Met-Hb, induced by the 
available high fat diet. CoQ10 supplementation was able to 
reverse all these variables demonstrating a systemic 
enhancement of antioxidant defenses. Moreover the 
antioxidant supplements decrease on 4-HNE that is a 
product of lipoperoxidation and 8-OHdG levels, which 
indicates DNA damage, both products increased on oxidative 
stress, thus complementing the beneficial effects performed 
by supplementation protocols27, 29. 
Pfeuffer and colleagues designed a clinical study in 
patients with MetS undergoing a 8-week protocol of 
quercetin supplementation. This is one of the few studies 
selected in the present systematic review that the humans 
composed the sample. In contrast with the beneficial 
findings, the supplementation of quercetin when analyzing  
APOE4 allele, demonstrated a high cardiovascular risk, and 
APOE3, appears to be a weak antioxidant supplement, due 
to the reduction in GSH concentration and higher TNF-α 
formation30. Also, Mohammadi and colleagues investigate 
the effects of curcumin supplementation on serum vitamin E 
levels in patients with MetS and found no significant 
difference, indicating that antioxidant effects of curcumin 
might be mainly directed by the modulatory effects on 
enzymatic antioxidant rather than non-enzymatic, like 
vitamin E55. In another study, it was not presented 
antioxidant effect with quercetin and concluded that both 
allele of APOE has same antioxidant capacity39. These 
findings are important to separate from experimental data 
with animals due to the fact that humans represent the ideal 
scenario of clinical changes of different potential antioxidant 
supplements. Not all experimental data observed in rats or 
mice are completely extrapolatable to humans. 
Antioxidant supplementation on glucose metabolism 
In MetS, combined with hyperglycemia occurs an 
increase of FFA and TG flux on blood, this supports 
impairment of insulin sensitivity, glucose intolerance, 
increase on blood glucose and glycated hemoglobin. 
Conversely, an enhancement on these factors was achieved 
by NS and garlic, SOD, α-lipoic acid, CoQ10, glycine, taurine, 
phenolic acids, goji berry and arginine supplementation21, 22, 
24, 25, 28, 50, 53, 54. Studies demonstrated that the improvement 
in antioxidant defense, consequently reducing oxidative 
stress, was related with a reduction of insulin resistance40, 41. 
Thereby follows a higher lipolytic activity, repairing HSL 
expression and decreasing the percentage of fibrous tissue, 
reducing adipocyte size and tissue, which might occur due to 
the improvement on insulin signaling performed by 
supplements. By this logic, insulin inhibits adipocyte lipolysis 
and enhances adipocyte differentiation, consequently 
increase insulin sensitivity, which leads to the reduction of 
fibrosis22, 40, 42. In this way, antioxidant supplementation 
could improve glucose metabolism through the increase of 
antioxidant activity in MetS condition leading to improve in 
insulin sensitivity.  
Antioxidant supplementation on inflammation 
The improvement in oxidative stress probably lead to 
reduced inflammation, idea supported by reducing 
inflammatory biomarkers, such as PCR, TNF-α, IL-6 and IL-8 
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after supplementation with antioxidants23, 26, 43, 50. Possibly 
owing to ROS up-regulating inflammatory genes, inducing 
nuclear factor (NF)-κB and increasing the expression of TNF-
α, IL-1, IL-6, which intensifies the inflammatory response 
(31). Beyond a decrease on central inflammation, the 
process might be related with positive effects on the limbic 
system when associated with cholecalciferol 
supplementation. This is supported that pro-inflammatory 
cytokines affects the permeability of blood brain barrier, so a 
decrease of the concentration of TNF-α in brain could lead to 
the improvement of cognition and memories latency 
period26, 44. Moreover, EPA:DHA mixtures diminishes PCR 
levels, indicating enhancement on systemic inflammation in 
mixtures with proportions of 1:1 and 2:1, however it was 
demonstrated an increase in VCAM, which is a marker of 
auxiliary inflammation, with 1:2 mixture. Hence, it seems 
that EPA performed a superior anti-inflammatory effect than 
DHA23, 26, 44, 45. In MetS scenario, a chronic inflammatory 
process is established, so the reduction of inflammation 
observed in the previous studies discussed might probably 
play a beneficial role in this disease. 
Antioxidant supplementation on endothelial function 
Once established the insulin resistance in MetS, a 
decrease of NO formation induced by insulin follows with 
an impairment of vasodilatation related to insulin, 
featuring an endothelial dysfunction9, 13. Improvement on 
endothelium function and decreasing high blood pressure 
can be attributed to antioxidant supplements by protecting 
against oxidative stress. Also, arginine supplementation 
was able to increase endothelium-dependent vasodilation 
and hyperreactivity to phenylephrinein, indicating that this 
supplement could reverse vascular dysfunction caused by 
metabolic syndrome54. Glycine supplementation was able 
to decrease systolic blood pressure through the increasing 
availability of NO via SNO-Hb, endothelium reservoir of NO 
being a blood pressure regulator and protect NO to react 
with anion superoxide and form peroxinitrite. The α-lipoic 
acid and CoQ10 supplementation decreased the impaired 
NO synthesis by preventing the upregulation of inducible 
nitric oxide synthase (iNOS). It is possible in view of a 
related reduction of ADMA, that is an inhibitor of 
endogenous NOS, besides it can possibly reverse an 
endothelial dysfunction by the decrease in perivascular 
lymphocytic infiltration24, 25, 46, 54. The antioxidant 
supplementation in experimental studies could ameliorate 
endothelial dysfunction, in view, that hypertension is one 
of the criteria for MetS diagnosis and oxidative stress has a 
major role in both of these conditions. 
Antioxidant supplementation on lipid profile 
In MetS, combined with hyperglycemia occurs augment on 
adipose lipolysis that lead to increase of lipid deposits on 
tissues, such as higher levels of LDL and lower levels of HDL. 
Lipid profile analysis demonstrated high levels of total 
cholesterol, LDL-c, triglycerides, fatty acids and lower on HDL-c 
levels. It is created the hypothesis that this condition is 
associated with the activation of sterol regulatory element 
binding protein-1C (SREBP-1c), which in turn contributes to lipid 
synthesis. When associated with antioxidant supplementation, 
such as F1, EPA:DHA, garlic, NS, queracetin, glycine, ALA, 
CoQ10, taurine, phenolic acids, red yeast rice-olive extract and 
goji berry levels of cholesterol, LDL-c, triglycerides and fatty acid 
are notably normalized, as well as, it was possible to observe an 
decrease in LDL oxidation and lower levels of Lp-PLA2, an 
enzyme that catalyses OxLDL hydrolysis, producing pro-
inflammatory mediators21, 23-25, 50, 51, 53. The proposed 
mechanism can be explained by preserving the activity of AMPK 
which suppresses FAS levels through inhibition of SREB1-c21, 23-25, 
27, 28, 30, 47. It was also observed that supplements appears to 
down-regulate the genes of 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA), which are activated in insulin 
resistance, hyperinsulinemia, by reducing expression of SREBP-
1c. Thus, the supplementation is responsible for inhibition of 
cholesterol synthesis and reduces LDL due to upregulation of 
LDL-receptor gene. In addition, taurine supplementation was 
able to reduce atherogenic index, associated to the decrease on 
total cholesterol observed with the supplementation28, 48, 49.  A 
beneficial role in lipid profile was observed in the studies 
reviewed, indicating a promissory effect of supplements with 
antioxidant potential in MetS. 
Antioxidant supplementation on cellular damage 
The antioxidant effect of these supplements lead to a 
reduction in oxidative stress, which is responsible to stress 
sensitive signaling system and promoters of apoptosis that 
could result in cellular damage. Besides the inflammatory 
process, the activation of NF-κB by the ROS formation lead 
to apoptosis and necrosis. It was also observed a suppression 
of the expression of c-Jun-NH2-terminal kinase (JNK) and 
p38 mitogen-activated protein kinase (p38MAP), as well as a 
decrease on apoptosis index associated with F1 
supplementation27, 28, 43. 
Limitations 
The present review has a limitation that explain 
discussion. Due to our search strategy the majority of studies 
included in this review are experimental ones, so the results 
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should be carefully extrapolated to human application. 
However, the studies reviewed were relevant to the field and 
pointed a promising effect of antioxidant supplementation 
on the metabolic syndrome Also, the experimental studies 
are crucial for further clinical trials, once the 
recommendation for clinical use of antioxidant supplements 
must be based in well-designed randomized clinical trials.   
CONCLUSION 
In conclusion, this review demonstrated that 
supplementation with antioxidant potential is able to 
ameliorate parameters of MetS. Antioxidant 
supplementation act improving the oxidative state by 
increasing antioxidant defense, which reduces oxidation of 
biomolecules. Furthermore, the supplementation could 
reduce inflammation, insulin impairment, and improve lipid 
profile and endothelium dysfunction. Thus, the 
supplementation with antioxidant potential could be the 
focus of further studies aiming to improve the complex and 
multifactorial scenario of MetS. 
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